Common metabolic enzyme could predict cancer immunotherapy benefits—and help more patients respond

Immunotherapies have transformed cancer treatment by helping the immune system recognize and attack tumors. They work for only about 20% of patients, though, and doctors still struggle to predict who will benefit.